Amino Terminal Pro-B-Type Natriuretic Peptide Predicts Mortality, Congestive Heart Failure, Stroke and Myocardial Infarction in the General Population but Not in the Absence of Traditional Cardiovascular Risk Factors or Structural Changes of the Heart